home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

29.49 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

99 100 Next >

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna and Sprinklr and Encourages Investors to Contact the Firm

August 18, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

MRNA Shareholder Notice: Robbins LLP Reminds Investors of the Class Action Filed Against Moderna, Inc.

August 18, 2024

From Robbins LLP

Via Business Wire

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

August 16, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Demystifying Moderna: Insights From 11 Analyst Reviews ↗

August 15, 2024

Via Benzinga

Moderna and Coursera Launch Free Course on mRNA Technology

August 14, 2024

Via ACCESSWIRE

Smart Money Is Betting Big In MRNA Options ↗

August 13, 2024

Via Benzinga

Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study ↗

August 16, 2024

Pfizer and BioNTech report Phase 3 results for their combined mRNA vaccine against influenza and COVID-19. The trial met one of two primary immunogenicity objectives. Adjustments are planned to improve...

Via Benzinga

MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

August 15, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

MODERNA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Moderna, Inc. and Encourages Investors to Contact the Firm

August 14, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Market Whales and Their Recent Bets on MRNA Options ↗

August 12, 2024

Via Benzinga

What the Options Market Tells Us About Moderna ↗

August 07, 2024

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,300 Today ↗

August 05, 2024

Via Benzinga

Stockholder Alert: Robbins LLP Informs Moderna, Inc. Stockholders that a Shareholder Filed a Class Action Against MRNA

August 14, 2024

From Robbins LLP

Via Business Wire

Stockholder Alert: Robbins LLP Informs Moderna, Inc. Stockholders that a Shareholder Filed a Class Action Against MRNA

August 14, 2024

From Robbins LLP

Via GlobeNewswire

MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm

August 14, 2024

From Schall Law

Via GlobeNewswire

Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows ↗

August 13, 2024

COVID-19 vaccinations could lower the incidence of heart attacks and strokes, according to a new study by UK universities. The research shows a significant reduction in cardiovascular events among...

Via Benzinga

Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows ↗

August 13, 2024

A recent NIH study reveals no clear diagnostic test for Long Covid, highlighting ongoing challenges in identifying and treating the condition affecting millions of Americans. Researchers continue to...

Via Benzinga

3 Biotech Stocks Poised for a Comeback After Last Week’s Market Meltdown ↗

August 13, 2024

Investors should closely watch these three biotech stocks as their strong prospects are likely to help the rebound from market volatility.

Via InvestorPlace

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

August 12, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 12, 2024

Via Benzinga

Novavax Plunges on Earnings Miss: Falling Knife or Buying Opp?

August 12, 2024

Novavax Inc. (NASDAQ: NVAX) is a biotechnology company that focuses on developing and commercializing vaccines for serious infectious diseases.

Via MarketBeat

MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm

August 10, 2024

From The Schall Law Firm

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

August 08, 2024

Via Benzinga

Expanding the Cloud for AI ↗

August 08, 2024

Amazon, Alphabet, Microsoft, and Meta are all spending a ton of money to build out cloud capabilities to fuel the next phase of AI growth. But the market isn't sold on that spend yet.

Via The Motley Fool

Topics Artificial Intelligence

3 Undervalued Stocks With Room to Rally Even Higher ↗

August 05, 2024

The latest market sell-off could be a great time to give the slate of undervalued stocks another look before tech reverses course.

Via InvestorPlace

Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again. ↗

August 05, 2024

Moderna sustained a rare downgrade on Monday following its guidance cut for the year.

Via Investor's Business Daily

Home Depot To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday ↗

August 05, 2024

Via Benzinga

BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products ↗

August 05, 2024

BioNTech posted a significant Q2 2024 loss of 807.8 million euros. Sales dropped to 128.7 million euros as the demand for COVID-19 vaccines shifted. R&D expenses rose due to late-stage oncology...

Via Benzinga

MicroStrategy, Intel And Moderna Are Among Top 12 Large Cap Losers Last Week (July 28-August 3): Are The Others In Your Portfolio? ↗

August 04, 2024

12 worst-performing large-cap stocks in the last week. Symbotic, Intel, Snap, Moderna, Mobileye, Pinterest, Arm, Entegris, Atlassian, MicroStrategy, New Oriental, and Western Digital.

Via Benzinga

Cathie Wood Bought This Stock After Its 27% Drop. Should You? ↗

August 04, 2024

This biotech company's promising pipeline could result in multibillion-dollar revenue.

Via The Motley Fool

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com